학술논문
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Document Type
Article
Author
Source
In Journal of Hepatology September 2022 77(3):607-618
Subject
Language
ISSN
0168-8278